CPT code 89251 covers laboratory culture of oocytes or embryos for fewer than four days with coculture as part of assisted reproductive technology (ART). This code captures a specific embryology laboratory procedure used in in vitro fertilization and related fertility treatments. As ART use grows, precise coding for laboratory services like short-term coculture affects clinical documentation and payer adjudication nationwide.

Key payers in this context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service represented by the code, its relevance to ART workflows, and the scope of payer coverage considered. The publication also provides benchmarks where available, notes on common billing modifiers, and context on how this procedure integrates into IVF service lines.

This summary is intended for national audiences including billing professionals, reproductive endocrinology practices, and payers seeking clarity on procedural classification and billing implications for short-duration oocyte or embryo coculture in ART.